Together, these data suggest that tumor cell-intrinsic IFN-I signaling is essential for antitumor CD8+ T cell response induction likely via DC activation and IL-1β production in the context of CD47-SIRPα blockade therapy. Here, SIRPA is linked to neoplasm.